What amount sold does Auvi Labs, Inc. report in Form D filings?

The latest linked filings report $543K sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Auvi Labs, Inc.'s most recent SEC filing?

Auvi Labs, Inc.'s most recent Form D filing was on 2026-08-26.

How many investors does Auvi Labs, Inc. have?

The most recent Form D filing lists 11 investor(s).

What type of securities does Auvi Labs, Inc. offer?

Auvi Labs, Inc.'s SEC Form D filings indicate debt offerings.

Auvi Labs, Inc.

CIK: 0002097988·Biotechnology·Chicago, IL·Corporation·Founded 2024

Reported Sold

$543,352

Total Filings

Identified Offerings

Last Filed

Aug 26, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Aug 26, 2026Form D — New notice

Reported sold: $442,352 · Target: Indefinite

Rule 506(b)·11 investors

Nov 24, 2025Form D — New notice

Reported sold: $101,000 · Target: $101,000

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$543,352

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Rishab Rao Veldur

Executive Officer, Director

Appears on 1 filing

Satyansh Yeluri

Director

Appears on 1 filing

Richard Li

Director

Appears on 1 filing

Kevin Volkema

Executive Officer, Director

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 26, 2026	New	Indefinite	$442,352	11
Nov 24, 2025	New	$101,000	$101,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Neopenda, PBC

Biotechnology

Offering target: $500,000

Filed Aug 27, 2026